Intravenous Toca 511 Delivery Leads to Viral DNA in Resected High Grade Glioma (HGG)

被引：0
|
作者：
Kalkanis, Steven N.
Vogelbaum, Michael
Bota, Daniela
Ostertag, Derek
Diego, Oscar
Jolly, Douglas
Skillings, Jamey
Yagiz, Kader
Robbins, Joan
Chu, Alice
Cloughesy, Timothy
机构：
来源：
JOURNAL OF NEUROSURGERY | 2016年 / 124卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
607
引用
收藏
页码：A1153 / A1153
页数：1
相关论文
共 50 条
  • [1] Toca 511 Followed by Toca FC in Subjects with Recurrent High Grade Glioma (HGG)
    Aghi, Manish K.
    Vogelbaum, Michael
    Cloughesy, Timothy
    Kesari, Santosh
    Portnow, Jana
    Ostertag, Derek
    Keller, Mary Rose
    Chu, Alice
    Skillings, Jamey
    Kaptain, George
    JOURNAL OF NEUROSURGERY, 2016, 124 (04) : A1154 - A1154
  • [2] SUCCESSFUL CANCER-SELECTIVE GENE DELIVERY FOLLOWING INTRAVENOUS TOCA 511 DELIVERY IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA (HGG)
    Cloughesy, Timothy
    Walbert, Tobias
    Bota, Daniela
    Vogelbaum, Michael
    Liau, Linda
    Ostertag, Derek
    Jolly, Douglas
    Gruber, Harry
    Yang, Liqiang
    Shorr, Jolene
    Kalkanis, Steven
    NEURO-ONCOLOGY, 2016, 18 : 17 - 17
  • [3] SUCCESSFUL CANCER-SELECTIVE GENE DELIVERY FOLLOWING INTRAVENOUS TOCA 511 DELIVERY IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA (HGG)
    Cloughesy, Timothy
    Walbert, Tobias
    Bota, Daniela
    Vogelbaum, Michael
    Liau, Linda
    Ostertag, Derek
    Jolly, Douglas
    Gruber, Harry
    Yang, Liqiang
    Shorr, Jolene
    Kalkanis, Steven
    NEURO-ONCOLOGY, 2016, 18 : 17 - 17
  • [4] INTRAVENOUS DELIVERY OF TOCA 511 IN PATIENTS WITH HIGH GRADE GLIOMA RESULTS IN QUANTIFIABLE EXPRESSION OF CYTOSINE DEAMINASE IN TUMOR TISSUE
    Walbert, Tobias
    Bota, Daniela
    Vogelbaum, Michael
    Kalkanis, Steven
    Liau, Linda
    Mikkelsen, Tom
    Gruber, Harry
    Shorr, Jolene
    Rodriguez-Aquirre, Maria
    Ostertag, Derek
    Mitchell, Leah
    Jolly, Douglas
    Cloughesy, Timothy
    NEURO-ONCOLOGY, 2017, 19 : 30 - 31
  • [5] TOCA 511 & TOCA FC VERSUS STANDARD OF CARE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
    Cloughesy, Timothy
    Petrecca, Kevin
    Walbert, Tobias
    Butowski, Nicholas
    Salacz, Michael
    Perry, James
    Damek, Denise
    Bota, Daniela
    Bettegowda, Chetan
    Zhu, Jay-Jiguang
    Iwamoto, Fabio
    Placantonakis, Dimitris
    Martinez, Nina
    Elder, J. Bradley
    Kaptain, George
    Cachia, David
    Moshel, Yaron
    Brem, Steven
    Picconi, David
    Nam Tran
    Nam, Do-Hyun
    Park, Chul-Kee
    Landolfi, Joseph
    Tran, David
    Ramakrishna, Rohan
    Fink, Karen
    Heros, Deborah
    Zadeh, Gelareh
    Nicholas, Garth
    Mehta, Vivek
    Robins, H. Ian
    Chen, Clark
    Pitz, Marshall
    Heth, Jason
    Nagpal, Seema
    Pearlman, Michael
    Ahluwalia, Manmeet
    Mohile, Nimish
    Merrell, Ryan
    Schiff, David
    Thompson, Reid
    Davis, Raphael
    Macdonald, David
    Kheoh, Thian
    Kabbinavar, Fairooz
    Lossos, Alexander
    Vogelbaum, Michael
    NEURO-ONCOLOGY, 2019, 21 : 284 - 284
  • [6] QUANTIFIABLE LEVELS OF THE TRANSGENE, CYTOSINE DEAMINASE, IN TUMOR SAMPLES FOLLOWING INTRAVENOUS DELIVERY OF TOCA 511 IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA
    Walbert, Tobias
    Bota, Danilella
    Vogelbaum, Michael
    Kalkanis, Steven
    Liau, Linda
    Mikkelsen, Tom
    Gruber, Harry
    Shorr, Jolene
    Rodriguez-Aguirre, Maria
    Ostertag, Derek
    Mitchell, Leah
    Jolly, Doug
    Cloughesy, Timothy
    NEURO-ONCOLOGY, 2017, 19 : 265 - 266
  • [7] Durable responses observed in recurrent high-grade glioma (rHGG) with Toca 511 and Toca FC treatment
    Cloughesy, Timothy F.
    Landolfi, Joseph
    Vogelbaum, Michael
    Ostertag, Derek
    Elder, Bradley
    Carter, Bob
    Chen, Clark C.
    Kalkanis, Steven
    Kesari, Santosh
    Lai, Albert
    Lee, Ian
    Liau, Linda
    Mikkelsen, Tom
    Nghiemphu, Leia
    Piccioni, David
    Accomando, William
    Diago, Oscar
    Hogan, Daniel
    Jolly, Douglas J.
    Wood, Katie
    Gruber, Harry
    Das, Asha
    Walbert, Tobias
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [8] EXTENDED BENEFITS IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA THAT CONTINUOUSLY RECEIVE TOCA FC AFTER TOCA 511 TREATMEN
    Walbert, Tobias
    Damek, Denise
    Martinez, Nina L.
    Piccioni, David
    Singer, Samuel
    Cloughesy, Timothy
    NEURO-ONCOLOGY, 2021, 23 : 58 - 59
  • [9] IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA
    Accomando, William
    Cloughesy, Timothy
    Kalkanis, Steven
    Mikkelsen, Tom
    Landolfi, Joseph
    Carter, Bob
    Chen, Clark
    Vogelbaum, Michael
    Elder, James
    Piccioni, David
    Walbert, Tobias
    Hogan, Daniel
    Diago, Oscar
    Gammon, Dawn
    Haghighi, Ali
    Kheoh, Thian
    Gruber, Harry
    Jolly, Douglas
    Ostertag, Derek
    NEURO-ONCOLOGY, 2018, 20 : 6 - 7
  • [10] DURABLE RESPONSES OBSERVED IN IDH1 WILDTYPE AND MUTANT RECURRENT HIGH GRADE GLIOMA (rHGG) WITH TOCA 511 & TOCA FC TREATMENT
    Cloughesy, Timothy
    Landolfi, Joseph
    Vogelbaum, Michael
    Ostertag, Derek
    Elder, Bradley
    Carter, Bob
    Chen, Clark
    Kalkanis, Steven
    Lai, Albert
    Mikkelsen, Tom
    Nghiemphu, Phioanh
    Piccioni, David
    Accomando, William
    Diago, Oscar
    Hogan, Daniel
    Jolly, Douglas
    Wood, Katie
    Yang, Liqiang
    Gruber, Harry
    Das, Asha
    Walbert, Tobias
    NEURO-ONCOLOGY, 2017, 19 : 26 - 26
12345